G A Obukhov. Show Affiliations »
Abstract
Mesh： See more » Acute DiseaseAntipsychotic Agents/administration & dosageAntipsychotic Agents/therapeutic useBasal Ganglia Diseases/chemically inducedBipolar Disorder/drug therapyChildChronic DiseaseDelayed-Action PreparationsDibenzazepines/therapeutic useDibenzothiepins/therapeutic useDosage FormsDrug Therapy, CombinationFluphenazine/administration & dosageFluphenazine/adverse effectsFluphenazine/therapeutic useHumansParanoid Disorders/drug therapyPerphenazine/administration & dosagePimozide/administration & dosagePimozide/therapeutic usePiperazines/therapeutic usePiperidines/adverse effectsPiperidines/therapeutic useSchizophrenia/drug therapyStructure-Activity RelationshipThioridazine/administration & dosageThioxanthenes/administration & dosageThioxanthenes/therapeutic useTranquilizing Agents/administration & dosage
Substances： See more » Antipsychotic AgentsDelayed-Action PreparationsDibenzazepinesDibenzothiepinsDosage FormsPiperazinesPiperidinesThioxanthenesTranquilizing AgentsPimozidePerphenazineThioridazineFluphenazine
Year: 1975 PMID： 235182
Source DB: PubMed Journal: Zh Nevropatol Psikhiatr Im S S Korsakova ISSN： 0044-4588